Changeflow GovPing Healthcare European Patent EP4678097A3 for Neural Interfac...
Routine Notice Added Final

European Patent EP4678097A3 for Neural Interface Implants

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Prosthetics (A61F)
Published March 18th, 2026
Detected March 23rd, 2026
Email

Summary

The European Patent Office has published patent EP4678097A3 for Synchron Australia Pty Limited, detailing systems and methods for controlling devices using detected changes in neural-related signals. The patent describes a neural interface implanted within a subject's brain to detect these signals and transmit input commands.

What changed

European patent EP4678097A3, titled 'SYSTEMS AND METHODS FOR CONTROLLING A DEVICE USING DETECTED CHANGES IN A NEURAL-RELATED SIGNAL,' was published by the EPO on March 18, 2026. The patent, assigned to Synchron Australia Pty Limited, outlines a method for controlling devices or software applications by detecting changes in a subject's neural-related signals, potentially using an implanted neural interface.

This publication represents the grant of a patent, not a regulatory requirement for compliance. Companies in the medical device and technology sectors involved in neural interfaces or brain-computer interfaces should note this patent for intellectual property and competitive landscape awareness. No immediate compliance actions are required for regulated entities based on this patent publication.

Source document (simplified)

← EPO Patent Bulletin

SYSTEMS AND METHODS FOR CONTROLLING A DEVICE USING DETECTED CHANGES IN A NEURAL-RELATED SIGNAL

Search Report EP4678097A3 Kind: A3 Mar 18, 2026

Applicants

Synchron Australia Pty Limited

Inventors

YOO, Peter Eli, OXLEY, Thomas James

Abstract

Systems and methods of controlling a device using detected changes in a neural-related signal of a subject are disclosed. In one embodiment, a method of controlling a device or software application comprises detecting a first change in a neural-related signal of a subject, detecting a second change in the neural-related signal, and transmitting an input command to the device upon or following the detection of the second change in the neural-related signal. The neural-related signal can be detected using a neural interface implanted within a brain of the subject.

IPC Classifications

G06F 3/01 20060101AFI20260206BHEP A61B 5/00 20060101ALI20260206BHEP G06F 3/023 20060101ALI20260206BHEP G06F 3/0482 20130101ALI20260206BHEP A61F 4/00 20060101ALI20260206BHEP A61F 2/72 20060101ALI20260206BHEP A61B 5/293 20210101ALI20260206BHEP A61B 5/03 20060101ALI20260206BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Applicants Inventors Abstract IPC Classifications Designated States

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4678097A3

Who this affects

Applies to
Medical device makers Technology companies
Industry sector
3345 Medical Device Manufacturing 5112 Software & Technology
Activity scope
Medical Device Development Brain-Computer Interface Technology
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
Product Development
Topics
Medical Devices Technology

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.